UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Analysis of TP53 Mutation Status in Human Cancer Cell Lines: A Reassessment

Human mutation, 2014-06, Vol.35 (6), p.756-765

2014

Volltextzugriff (PDF)

Phosphatidylinositol-3-OH Kinase or RAS Pathway Mutations in Human Breast Cancer Cell Lines

Molecular cancer research, 2007-02, Vol.5 (2), p.195-201

2007

Volltextzugriff (PDF)

Erratum to ‘The benefit of adding polygenic risk scores, lifestyle factors, and breast density to family history and genetic status for breast cancer risk and surveillance classification of unaffected women from germline CHEK2 c.1100delC families’ [The Breast 73 (2024) 103611]

Breast (Edinburgh), 2024-06, Vol.75, p.103723, Article 103723

2024

Volltextzugriff (PDF)

The benefit of adding polygenic risk scores, lifestyle factors, and breast density to family history and genetic status for breast cancer risk and surveillance classification of unaffected women from germline CHEK2 c.1100delC families

Breast (Edinburgh), 2024-06, Vol.75, p.103724, Article 103724

2024

Volltextzugriff (PDF)

miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs

Breast cancer research : BCR, 2013-04, Vol.15 (2), p.R33-R33, Article R33

2013

Volltextzugriff (PDF)

The benefit of adding polygenic risk scores, lifestyle factors, and breast density to family history and genetic status for breast cancer risk and surveillance classification of unaffected women from germline CHEK2 c.1100delC families

Breast (Edinburgh), 2024-02, Vol.73, p.103611-103611, Article 103611

2024

Volltextzugriff (PDF)

Progression-free survival and overall survival after BRCA1/2-associated epithelial ovarian cancer: A matched cohort study

PloS one, 2022-09, Vol.17 (9), p.e0275015-e0275015

2022

Volltextzugriff (PDF)

Breast cancer genomes from CHEK2 c.1100delC mutation carriers lack somatic TP53 mutations and display a unique structural variant size distribution profile

Breast cancer research : BCR, 2023-05, Vol.25 (1), p.53-53, Article 53

2023

Volltextzugriff (PDF)

Low Tumor Mitochondrial DNA Content Is Associated with Better Outcome in Breast Cancer Patients Receiving Anthracycline-Based Chemotherapy

Clinical cancer research, 2017-08, Vol.23 (16), p.4735-4743

2017

Volltextzugriff (PDF)

Elucidating the Underlying Functional Mechanisms of Breast Cancer Susceptibility Through Post-GWAS Analyses

Frontiers in genetics, 2018-08, Vol.9, p.280-280

2018

Volltextzugriff (PDF)

A 3′-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis

The lancet oncology, 2011-04, Vol.12 (4), p.377-386

2011

Volltextzugriff (PDF)

BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants

Cancer research (Chicago, Ill.), 2006, Vol.66 (1), p.41-45

2006

Volltextzugriff (PDF)

A pipeline for copy number profiling of single circulating tumour cells to assess intrapatient tumour heterogeneity

Molecular oncology, 2022-08, Vol.16 (16), p.2981-3000

2022

Volltextzugriff (PDF)

The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer

PloS one, 2016-08, Vol.11 (8), p.e0161731-e0161731

2016

Volltextzugriff (PDF)

Tumor-associated inflammation as a potential prognostic tool in BRCA1/2 -associated breast cancer

Human pathology, 2015-02, Vol.46 (2), p.182-190

2015

Volltextzugriff (PDF)

CHEK21100delC homozygosity in the Netherlands--prevalence and risk of breast and lung cancer

European journal of human genetics : EJHG, 2014-01, Vol.22 (1), p.46-51

2014

Volltextzugriff (PDF)

E-cadherin promotor methylation and mutation are inversely related to motility capacity of breast cancer cells

Breast cancer research and treatment, 2012-11, Vol.136 (2), p.365-377

2012

Volltextzugriff (PDF)

Low-risk susceptibility alleles in 40 human breast cancer cell lines

BMC cancer, 2009-07, Vol.9 (1), p.236-236, Article 236

2009

Volltextzugriff (PDF)

Comment Re: MDA-MB-435 and M14 cell lines: identical but not M14 Melanoma?

Cancer research (Chicago, Ill.), 2009-10, Vol.69 (19), p.7893-7893

2009

Volltextzugriff (PDF)

Rare BRCA1 haplotypes including 3'UTR SNPs associated with breast cancer risk

Cell cycle (Georgetown, Tex.), 2011-01, Vol.10 (1), p.90-99

2011

Volltextzugriff (PDF)

Exon expression arrays as a tool to identify new cancer genes

PloS one, 2008-08, Vol.3 (8), p.e3007-e3007

2008

Volltextzugriff (PDF)

Genetically Predicted Levels of DNA Methylation Biomarkers and Breast Cancer Risk: Data From 228 951 Women of European Descent

JNCI : Journal of the National Cancer Institute, 2020-03, Vol.112 (3), p.295-304

2020

Volltextzugriff (PDF)

Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-BRCA1/2 breast cancer families

Journal of medical genetics, 2019-09, Vol.56 (9), p.581-589

2019

Volltextzugriff (PDF)

Clinical applicability of the Polygenic Risk Score for breast cancer risk prediction in familial cases

Journal of medical genetics, 2023-04, Vol.60 (4), p.327-336

2023

Volltextzugriff (PDF)

1 – 25 von 67

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(67)

Sprache

Englisch
(67)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Breast Cancer Research And Treatment
(12)
Cancer Research
(6)
Cancers
(6)
Breast Cancer Research
(5)
Breast Cancer Research : Bcr
(5)
Nature Genetics
(5)
Breast
(3)
Plos One
(3)
Cell Cycle
(2)
Jnci : Journal Of The National Cancer Institute
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Analysis of TP53 Mutation Status in Human Cancer Cell Lines: A Reassessment

Phosphatidylinositol-3-OH Kinase or RAS Pathway Mutations in Human Breast Cancer Cell Lines

Erratum to ‘The benefit of adding polygenic risk scores, lifestyle factors, and breast density to family history and genetic status for breast cancer risk and surveillance classification of unaffected women from germline CHEK2 c.1100delC families’ [The Breast 73 (2024) 103611]

The benefit of adding polygenic risk scores, lifestyle factors, and breast density to family history and genetic status for breast cancer risk and surveillance classification of unaffected women from germline CHEK2 c.1100delC families

miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs

The benefit of adding polygenic risk scores, lifestyle factors, and breast density to family history and genetic status for breast cancer risk and surveillance classification of unaffected women from germline CHEK2 c.1100delC families

Progression-free survival and overall survival after BRCA1/2-associated epithelial ovarian cancer: A matched cohort study

Breast cancer genomes from CHEK2 c.1100delC mutation carriers lack somatic TP53 mutations and display a unique structural variant size distribution profile

Low Tumor Mitochondrial DNA Content Is Associated with Better Outcome in Breast Cancer Patients Receiving Anthracycline-Based Chemotherapy

Elucidating the Underlying Functional Mechanisms of Breast Cancer Susceptibility Through Post-GWAS Analyses

A 3′-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis

BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants

Cohort profile: a nationwide study in Dutch CHEK2 c.1100delC families using the infrastructure of the HEreditary Breast and Ovarian cancer study Netherlands – Hebon-CHEK2

A pipeline for copy number profiling of single circulating tumour cells to assess intrapatient tumour heterogeneity

The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer

Tumor-associated inflammation as a potential prognostic tool in BRCA1/2 -associated breast cancer

CHEK21100delC homozygosity in the Netherlands--prevalence and risk of breast and lung cancer

E-cadherin promotor methylation and mutation are inversely related to motility capacity of breast cancer cells

Low-risk susceptibility alleles in 40 human breast cancer cell lines

Comment Re: MDA-MB-435 and M14 cell lines: identical but not M14 Melanoma?

Rare BRCA1 haplotypes including 3'UTR SNPs associated with breast cancer risk

Exon expression arrays as a tool to identify new cancer genes

Genetically Predicted Levels of DNA Methylation Biomarkers and Breast Cancer Risk: Data From 228 951 Women of European Descent

Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-BRCA1/2 breast cancer families

Clinical applicability of the Polygenic Risk Score for breast cancer risk prediction in familial cases

Suchergebnisse filtern